These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10886720)

  • 21. Alternative versus classical macrophage activation during experimental African trypanosomosis.
    Baetselier PD; Namangala B; Noël W; Brys L; Pays E; Beschin A
    Int J Parasitol; 2001 May; 31(5-6):575-87. PubMed ID: 11334945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation.
    Ramachandra L; Qu Y; Wang Y; Lewis CJ; Cobb BA; Takatsu K; Boom WH; Dubyak GR; Harding CV
    Infect Immun; 2010 Dec; 78(12):5116-25. PubMed ID: 20837713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
    Herrera OB; Brett S; Lechler RI
    Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-gamma differentially regulates antigen-processing functions in distinct endocytic compartments of macrophages with constitutive expression of class II major histocompatibility complex molecules.
    Hockett RD; Cook JR; Findlay K; Harding CV
    Immunology; 1996 May; 88(1):68-75. PubMed ID: 8707353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.
    Tobian AA; Potter NS; Ramachandra L; Pai RK; Convery M; Boom WH; Harding CV
    J Immunol; 2003 Aug; 171(3):1413-22. PubMed ID: 12874233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition.
    Andris F; Leo O; Van Mechelen M; Urbain J; Slaoui M
    Immunology; 1989 Sep; 68(1):1-6. PubMed ID: 2530152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages.
    Noss EH; Harding CV; Boom WH
    Cell Immunol; 2000 Apr; 201(1):63-74. PubMed ID: 10805975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine T lymphocyte specificity for African trypanosomes. II. Suppression of the T lymphocyte proliferative response to Trypanosoma brucei by systemic trypanosome infection.
    Gasbarre LC; Hug K; Louis J
    Clin Exp Immunol; 1981 Jul; 45(1):165-72. PubMed ID: 6458434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico identification of novel protective VSG antigens expressed by Trypanosoma brucei and an effort for designing a highly immunogenic DNA vaccine using IL-12 as adjuvant.
    Akhoon BA; Slathia PS; Sharma P; Gupta SK; Verma V
    Microb Pathog; 2011; 51(1-2):77-87. PubMed ID: 21349321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
    Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
    J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.
    Murphy B; Magee CC; Alexander SI; Waaga AM; Snoeck HW; Vella JP; Carpenter CB; Sayegh MH
    J Clin Invest; 1999 Mar; 103(6):859-67. PubMed ID: 10079107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycobacterium tuberculosis PPE18 protein inhibits MHC class II antigen presentation and B cell response in mice.
    Dolasia K; Nazar F; Mukhopadhyay S
    Eur J Immunol; 2021 Mar; 51(3):603-619. PubMed ID: 33084017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
    Adams S; Humphreys RE
    Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune responses to self peptides naturally presented by murine class II major histocompatibility complex molecules.
    Rider BJ; Fraga E; Yu Q; Singh B
    Mol Immunol; 1996; 33(7-8):625-33. PubMed ID: 8760274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental African trypanosomiasis: lack of effective CD1d-restricted antigen presentation.
    Shi MQ; Wang CR; Wei GJ; Pan WL; Appleyard G; Tabel H
    Parasite Immunol; 2006 Dec; 28(12):643-7. PubMed ID: 17096643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophages present exogenous antigens by class I major histocompatibility complex molecules via a secretory pathway as a consequence of interferon-gamma activation.
    Martín-Orozco N; Isibasi A; Ortiz-Navarrete V
    Immunology; 2001 May; 103(1):41-8. PubMed ID: 11380691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
    Carstens C; Newman DK; Bohlen H; König A; Koch N
    Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased interleukin-2 responsiveness in leukocytes from Trypanosoma brucei-infected mice.
    Bowlin TL; Bitonti AJ; McKown BJ
    Cell Immunol; 1988 Apr; 112(2):437-41. PubMed ID: 3128404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells.
    Harding CV; Geuze HJ
    J Cell Biol; 1992 Nov; 119(3):531-42. PubMed ID: 1400590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.